Lindbrook Capital, LLC Relay Therapeutics, Inc. Transaction History
Lindbrook Capital, LLC
- $1.06 Billion
- Q2 2024
A detailed history of Lindbrook Capital, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 645 shares of RLAY stock, worth $4,186. This represents 0.0% of its overall portfolio holdings.
Number of Shares
645
Previous 341
89.15%
Holding current value
$4,186
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RLAY
# of Institutions
182Shares Held
126MCall Options Held
1.7KPut Options Held
18K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$181 Million1.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$76 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$68.4 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.45MShares$54.8 Million4.77% of portfolio
-
Bellevue Group Ag Kuesnacht, V86.38MShares$41.4 Million0.7% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $780M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...